Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells

DOI PDF 4 Citations
  • Eric S. Yvon
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Stephane Vigouroux
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Raphael F. Rousseau
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Ettore Biagi
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Persis Amrolia
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Gianpietro Dotti
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Hans-Joachim Wagner
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Malcolm K. Brenner
    From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.

Abstract

<jats:title>Abstract</jats:title><jats:p>Graft-versus-host disease (GVHD) represents one of the major complications of allogeneic hematopoietic stem cell transplantation. Techniques to prevent GVHD have included ex vivo T-cell depletion of the graft or prolonged in vivo immunosuppression. Both reduce the frequency and severity of GVHD but also reduce T-cell-mediated graft-versus-malignancy effect, and increase the risk of infection. A major goal in transplantation is to prevent alloreactivity while preserving activity against tumors and infectious agents. We have used activation of the Notch pathway to try to generate T cells able to specifically regulate alloantigen responses. We used allogeneic Epstein-Barr virus lymphoblastoid B cells (EBV-LCLs) as stimulator cells. Such LCLs are excellent (allo) antigen-presenting cells and can be obtained in large numbers even from donors who have received extensive chemo/radiotherapy. We overexpressed a Notch ligand, Jagged-1, in these cells by adenoviral vector transduction. Stimulation of CD45RA+ naive T cells by Jagged-1 EBV-LCL reduces production of interferon-γ, interleukin-2, and interleukin-5, but up-regulates transforming growth factor-β1 synthesis, consistent with induction of a regulatory T-cell phenotype. Transfer of these T cells to fresh lymphocyte cultures inhibits proliferative and cytotoxic immune responses to the priming alloantigens while sparing responses to third-party stimulator cells. Notch activation in the presence of alloantigen-presenting cells may therefore be a means of inducing specific regulatory T cells while preserving other T-cell functionality. (Blood. 2003;102:3815-3821)</jats:p>

Journal

  • Blood

    Blood 102 (10), 3815-3821, 2003-11-15

    American Society of Hematology

Citations (4)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top